Related Experiment Video

Updated: Nov 15, 2025

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
06:29

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Published on: May 25, 2022

2.6K

Ophthalmological Considerations for COVID-19 Vaccination in Patients with Inflammatory Eye Diseases and Autoimmune

Charlene Y C Chau1, Loraine L W Chow1, Siddharth Sridhar2

  • 1Department of Ophthalmology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong SAR.

Ophthalmology and Therapy
|March 6, 2021
PubMed

Insights

COVID-19 vaccines offer hope, but patients with inflammatory eye diseases require special consideration. Further research on vaccine safety and effectiveness in this group is crucial for personalized care.

Area of Science:

  • Ophthalmology
  • Immunology
  • Vaccinology

Background:

  • The COVID-19 pandemic's global impact is being addressed by vaccine development and rollout.
  • Physicians need to identify vulnerable patient groups for specific advice regarding vaccination.
  • Patients with inflammatory eye diseases represent a unique group requiring careful consideration for COVID-19 vaccination.

Purpose of the Study:

  • To analyze key considerations for administering COVID-19 vaccines to patients with inflammatory eye diseases.
  • To discuss the importance of scrutinizing vaccine immunogenicity and potential adverse effects in this population.
  • To highlight the need for further research to guide personalized management strategies.

Main Methods:

  • Commentary analyzing existing data and scientific literature.
  • Discussion of vaccine immunogenicity and adverse effects, including antibody-dependent enhancement.
  • Review of considerations for patient counseling and management.

Main Results:

  • Vaccine development for COVID-19 has been rapid and unprecedented.
  • Patients with inflammatory eye diseases may require tailored advice due to potential interactions with vaccines.
  • Antibody-dependent enhancement is a critical factor to consider regarding vaccine safety.

Conclusions:

  • Careful consideration of COVID-19 vaccine immunogenicity and adverse effects is essential for patients with inflammatory eye diseases.
  • Further pharmacovigilance research is needed to develop personalized guidelines for this patient group.
  • Informed counseling is vital for patients with inflammatory eye diseases undergoing vaccination.
Keywords:
Autoimmune disordersCOVID-19Inflammatory eye diseaseOphthalmic considerationsPandemicVaccination

More Related Videos

Induction of Ocular Surface Inflammation and Collection of Involved Tissues06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.5K
Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology06:19

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology

Published on: May 31, 2024

1.2K

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
818
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
944
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
Accessory Structures of the Eye01:17

Accessory Structures of the Eye

Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
2.7K